V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10436554 | 10033151 | 1.63 | 67.4 | Palliative (P) | null | 2019-10-20 | Capecitabine | 02 | N | CAPECITABINE | 101094342 |
| 10436562 | 10033152 | 1.6 | 98.8 | null | 2018-01-10 | 2018-01-10 | Capecitabine + Oxaliplatin 21day | N | N | RITUXIMAB | 100205708 |
| 10436572 | 10033153 | 1.57 | 62.1 | Adjuvant (A) | 2014-08-06 | 2019-12-07 | IBRUTINIB | N | N | IBRUTINIB | 100938262 |
| 10436594 | 10033154 | 1.66 | 71 | 03 | 2019-05-18 | 2019-05-30 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100205810 |
| 10436626 | 10033155 | 1.64 | 85 | Palliative (P) | 2020-08-09 | 2020-09-19 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100134029 |
| 10436628 | 10033156 | 1.67 | 68 | Palliative (P) | 2019-02-12 | 2019-02-23 | Rituximab | 02 | N | RITUXIMAB | 100139224 |
| 10436631 | 10033157 | 1.75 | 82.8 | Palliative (P) | 2015-06-23 | 2016-02-16 | Docetaxel | 02 | N | DOCETAXEL | 100361871 |
| 10436632 | 10033158 | 1.66 | 76.2 | Curative (C) | 2018-01-07 | 2018-01-09 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 100199741 |
| 10436641 | 10033159 | 1.72 | 74.4 | Curative (C) | 2019-12-08 | 2019-12-18 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101744550 |
| 10436646 | 10033160 | 1.78 | 89 | Palliative (P) | 2018-01-22 | 2018-01-31 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100605082 |
| 10436649 | 10033161 | 1.65 | 60 | Curative (C) | 2017-09-25 | 2017-10-08 | CAPECITABINE + OXALIPLATIN | N | N | RITUXIMAB | 101193014 |
| 10436653 | 10033162 | 1.78 | 53.9 | 03 | 2018-07-30 | 2018-08-07 | Capecitabine 5days + RT | 01 | N | CAPECITABINE | 100487519 |
| 10436683 | 10033163 | 1.72 | 97 | Disease modification (D) | 2019-11-22 | 2019-11-22 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101144589 |
| 10436689 | 10033164 | 1.8 | 53 | Palliative (P) | 2021-04-13 | 2021-04-13 | Rituximab | 02 | null | RITUXIMAB | 101505739 |
| 10436710 | 10033165 | null | null | null | 2019-07-05 | 2019-07-05 | IBRUTINIB | null | null | IBRUTINIB | 100439601 |
| 10436715 | 10033166 | 1.71 | 44.6 | null | 2021-12-25 | 2021-12-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101753255 |
| 10436723 | 10033167 | 1.75 | 85.1 | Palliative (P) | 2018-04-16 | 2018-04-17 | Capecitabine | 02 | N | CAPECITABINE | 101058637 |
| 10436768 | 10033168 | 1.82 | null | Palliative (P) | 2021-04-08 | 2021-04-14 | Capecitabine 42days + RT | 02 | N | CAPECITABINE | 100159664 |
| 10436774 | 10033169 | 1.59 | 84.7 | null | 2016-02-12 | 2016-02-18 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101818121 |
| 10436795 | 10033170 | 1.72 | 80 | 03 | 2016-02-22 | 2016-10-19 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100424812 |
| 10436813 | 10033171 | 1.52 | 95.9 | Curative (C) | 2017-01-21 | 2017-01-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101800244 |
| 10436826 | 10033172 | null | 87 | Curative (C) | 2016-05-27 | 2016-06-11 | Capecitabine + Oxaliplatin 21day | N | N | PEMBROLIZUMAB | 101769809 |
| 10436836 | 10033173 | 1.66 | 69 | Palliative (P) | 2020-10-06 | 2020-10-06 | IBRUTINIB | N | N | IBRUTINIB | 100870130 |
| 10436849 | 10033174 | 1.58 | 64 | Neo-adjuvant (N) | 2021-09-23 | 2021-10-07 | Docetaxel 100mg/m2 (21 day) | 02 | Y | DOCETAXEL | 100834823 |
| 10436853 | 10033175 | 1.67 | 101.9 | null | 2020-01-02 | 2020-01-12 | Capecitabine | 02 | null | CAPECITABINE | 101853681 |
| 10436887 | 10033176 | 1.78 | 69 | null | 2021-11-29 | 2021-11-29 | Capecitabine | 02 | null | CAPECITABINE | 100372298 |
| 10436908 | 10033177 | 1.78 | 85.8 | Neo-adjuvant (N) | 2021-04-07 | 2021-04-08 | Rituximab | 02 | null | RITUXIMAB | 100328117 |
| 10436949 | 10033178 | 1.6 | 0 | null | 2020-09-06 | 2020-09-17 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100283889 |
| 10436962 | 10033179 | 1.65 | 92.2 | Palliative (P) | 2018-05-27 | 2018-07-01 | Rituximab | 02 | N | RITUXIMAB | 100263269 |
| 10436963 | 10033180 | 1.71 | 62.6 | Neo-adjuvant (N) | 2017-07-31 | 2017-08-08 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101823247 |
| 10436978 | 10033181 | 1.61 | 88.3 | 03 | 2018-02-06 | 2018-02-20 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101211052 |
| 10437001 | 10033182 | 1.68 | 88 | Curative (C) | 2020-02-01 | 2020-02-01 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100291667 |
| 10437069 | 10033183 | 1.77 | 106 | 03 | 2019-12-02 | 2019-12-09 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100321064 |
| 10437084 | 10033184 | null | 89.1 | Adjuvant (A) | 2017-10-20 | 2019-08-07 | IBRUTINIB | N | N | IBRUTINIB | 100776729 |
| 10437112 | 10033185 | 1.82 | 85.5 | null | 2021-10-18 | 2021-10-23 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100590515 |
| 10437122 | 10033186 | 1.81 | 62.1 | Disease modification (D) | 2016-08-01 | 2016-08-04 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100690182 |
| 10437140 | 10033187 | 1.75 | 83 | null | 2021-12-02 | 2021-12-13 | Rituximab | 02 | null | RITUXIMAB | 100920284 |
| 10437154 | 10033188 | 1.65 | 0 | null | 2020-12-22 | 2020-12-29 | Rituximab | 02 | null | RITUXIMAB | 101170063 |
| 10437155 | 10033189 | 1.58 | 66 | Palliative (P) | 2018-10-23 | 2018-10-29 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101325246 |
| 10437167 | 10033190 | 1.72 | 64.1 | Palliative (P) | null | 2017-06-13 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101404195 |
| 10437199 | 10033191 | 1.55 | 66.9 | Palliative (P) | 2017-06-19 | 2017-06-19 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100596222 |
| 10437202 | 10033192 | 1.63 | 79 | Palliative (P) | 2016-10-22 | 2016-10-30 | IBRUTINIB | 02 | N | IBRUTINIB | 101468682 |
| 10437214 | 10033193 | 1.88 | 58.2 | Adjuvant (A) | 2017-08-16 | 2017-08-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100498570 |
| 10437247 | 10033194 | null | 119.2 | Curative (C) | 2018-05-04 | 2018-05-05 | Rituximab | 02 | null | RITUXIMAB | 100325402 |
| 10437261 | 10033195 | 1.52 | 78 | Palliative (P) | 2018-06-09 | 2018-06-12 | IBRUTINIB | 02 | N | IBRUTINIB | 101275797 |
| 10437297 | 10033196 | 1.81 | 84.85 | null | 2020-01-30 | 2020-02-04 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100894464 |
| 10437313 | 10033197 | 0 | 73.3 | 03 | 2016-05-27 | 2016-06-18 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101457975 |
| 10437323 | 10033198 | 1.72 | 64 | Adjuvant (A) | null | 2017-07-11 | CAPECITABINE + OXALIPLATIN | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100153927 |
| 10437348 | 10033199 | 1.72 | 80.2 | null | 2017-08-20 | 2017-08-27 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100619301 |
| 10437350 | 10033200 | 1.78 | 62.5 | Palliative (P) | 2020-06-10 | 2020-06-13 | Rituximab | 02 | N | RITUXIMAB | 100365112 |